Lessons from genome-wide studies of melanoma: towards precision medicine

References

• Nikolaou V, Stratigos AJ. Emerging trends in the epidemiology of melanoma. Br J Dermatol. 2014;170(1):11–19.
   PubMed Web of Science ®Google Scholar
• Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 1996;73(12):1605–1611.
   PubMed Web of Science ®Google Scholar
• Titus-Ernstoff L, Perry AE, Spencer SK, et al. Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer. 2005;116(1):144–149.
   PubMed Web of Science ®Google Scholar
• Shain AH, Bastian BC. From melanocytes to melanomas. Nat Rev Cancer. 2016;16(6):345–358.
   PubMed Web of Science ®Google Scholar
• Gandini S, Montella M, Ayala F, et al. Sun exposure and melanoma prognostic factors. Oncol Lett. 2016;11(4):2706–2714.
   PubMed Web of Science ®Google Scholar
• Antonopoulou K, Stefanaki I, Lill CM, et al. Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database. J Invest Dermatol. 2015;135(4):1074–1079.
   PubMed Web of Science ®Google Scholar
• Vuong K, McGeechan K, Armstrong BK, et al. Risk prediction models for incident primary cutaneous melanoma: a systematic review. JAMA Dermatol. 2014;150(4):434–444.
   PubMed Web of Science ®Google Scholar
• Davies JR, Chang YM, Bishop DT, et al. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiol Biomarkers Prev. 2015;24(5):817–824.
   PubMed Web of Science ®Google Scholar
• Olsen CM, Neale RE, Green AC, et al. Independent validation of six melanoma risk prediction models. J Invest Dermatol. 2015;135(5):1377–1384.
   PubMed Web of Science ®Google Scholar
• Manolio TA. Bringing genome-wide association findings into clinical use. Nat Rev Genet. 2013;14(8):549–558.
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747–753.
   PubMed Web of Science ®Google Scholar
• Panagiotou OA, Evangelou E, Ioannidis JP. Genome-wide significant associations for variants with minor allele frequency of 5% or less–an overview: a huge review. Am J Epidemiol. 2010;172(8):869–889.
   PubMed Web of Science ®Google Scholar
• Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42(Database issue):D1001–6.
   PubMed Web of Science ®Google Scholar
• Panagiotou OA, Willer CJ, Hirschhorn JN, et al. The power of meta-analysis in genome-wide association studies. Annu Rev Genomics Hum Genet. 2013;14:441–465.
   PubMed Web of Science ®Google Scholar
• Evangelou E, Ioannidis JP. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet. 2013;14(6):379–389.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One. 2007;2(9):e841.
   PubMed Web of Science ®Google Scholar
• Georgiopoulos G, Evangelou E. Power considerations for lambda inflation factor in meta-analyses of genome-wide association studies. Genet Res (Camb). 2016;98:e9.
   PubMedGoogle Scholar
• Homer N, Szelinger S, Redman M, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet. 2008;4(8):e1000167.
   PubMed Web of Science ®Google Scholar
• Segre AV, Groop L, Mootha V. K, DIAGRAM Consortium, MAGIC Investigators, et al. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 2010;6:8.
   Google Scholar
• Pers TH, Karjalainen JM, Chan Y, et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat Commun. 2015;6:5890.
   PubMed Web of Science ®Google Scholar
• Spain SL, Barrett JC. Strategies for fine-mapping complex traits. Hum Mol Genet. 2015;24(R1):R111–9.
   PubMedGoogle Scholar
• Brown KM, Macgregor S, Montgomery GW, et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet. 2008;40(7):838–840.
   PubMed Web of Science ®Google Scholar
• Bishop DT, Demenais F, Iles MM, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet. 2009;41(8):920–925.
   PubMed Web of Science ®Google Scholar
• Amos CI, Wang LE, Lee JE, et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet. 2011;20(24):5012–5023.
   PubMed Web of Science ®Google Scholar
• Barrett JH, Iles MM, Harland M, et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet. 2011;43(11):1108–1113.
   PubMed Web of Science ®Google Scholar
• Macgregor S, Montgomery GW, Liu JZ, et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet. 2011;43(11):1114–1118.
   PubMed Web of Science ®Google Scholar
• Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet. 2013;45(4):428–32, 432e1.
   PubMed Web of Science ®Google Scholar
• Chatzinasiou F, Lill CM, Kypreou K, et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst. 2011;103(16):1227–1235.
   PubMedGoogle Scholar
• Athanasiadis EI, Antonopoulou K, Chatzinasiou F, et al. A web-based database of genetic association studies in cutaneous melanoma enhanced with network-driven data exploration tools. Database (Oxford). 2014. [Open access journal].
   PubMed Web of Science ®Google Scholar
• Law MH, Bishop DT, Lee JE, et al. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet. 2015;47(9):987–995.
   PubMed Web of Science ®Google Scholar
• Stefanaki I, Panagiotou OA, Kodela E, et al. Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control study. PLoS One. 2013;8(2):e55712.
   PubMedGoogle Scholar
• Fang S, Han J, Zhang M, et al. Joint effect of multiple common SNPs predicts melanoma susceptibility. PLoS One. 2013;8(12):e85642.
   PubMedGoogle Scholar
• Kypreou KP, Stefanaki I, Antonopoulou K, et al. Prediction of melanoma risk in a Southern European population based on a weighted genetic risk score. J Invest Dermatol. 2016;136(3):690–695.
   PubMed Web of Science ®Google Scholar
• Zhang C, Doherty JA, Burgess S, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet. 2015;24(18):5356–5366.
   PubMed Web of Science ®Google Scholar
• Nan H, Qureshi AA, Prescott J, et al. Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet. 2011;129(3):247–253.
   PubMed Web of Science ®Google Scholar
• Bataille V, Kato BS, Falchi M, et al. Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1499–1502.
   PubMed Web of Science ®Google Scholar
• Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129(2):415–421.
   PubMed Web of Science ®Google Scholar
• Burke LS, Hyland PL, Pfeiffer RM, et al. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One. 2013;8(8):e71121.
   PubMedGoogle Scholar
• Iles MM, Bishop DT, Taylor JC, et al. The effect on melanoma risk of genes previously associated with telomere length. J Natl Cancer Inst. 2014;106:10.
   Google Scholar
• Kingsley CB. Identification of causal sequence variants of disease in the next generation sequencing era. Methods Mol Biol. 2011;700:37–46.
   PubMedGoogle Scholar
• Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.
   PubMed Web of Science ®Google Scholar
• Siva N. UK gears up to decode 100,000 genomes from NHS patients. Lancet. 2015;385(9963):103–104.
   PubMed Web of Science ®Google Scholar
• Shah SH, Arnett D, Houser SR, et al. Opportunities for the Cardiovascular community in the precision medicine initiative. Circulation. 2016;133(2):226–231.
   PubMed Web of Science ®Google Scholar
• Ball MP, Thakuria JV, Zaranek AW, et al. A public resource facilitating clinical use of genomes. Proc Natl Acad Sci USA. 2012;109(30):11920–11927.
   PubMed Web of Science ®Google Scholar
• Lunshof JE, Bobe J, Aach J, et al. Personal genomes in progress: from the human genome project to the personal genome project. Dialogues Clin Neurosci. 2010;12(1):47–60.
   PubMedGoogle Scholar
• Overby CL, Heale B, Aronson S, et al. Providing access to genomic variant knowledge in a healthcare setting: a vision for the Clingen electronic health records workgroup. Clin Pharmacol Ther. 2016;99(2):157–160.
   PubMed Web of Science ®Google Scholar
• Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526(7573):336–342.
   PubMed Web of Science ®Google Scholar